Results 101 to 109 of about 132 (109)

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

Lancet, The, 2007
Christoph Stettler, Simon Wandel, Sabin Allemann   +2 more
exaly  

Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents

Circulation, 2012
Sripal Bangalore, Michael J Attubato, Frederick Feit   +2 more
exaly  

Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease

Circulation, 2018
Sripal Bangalore, Bora Toklu, Frederick Feit   +2 more
exaly  

Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”

Circulation, 2004
Pedro A Lemos, Francesco Saia, Chourmouzios A Arampatzis   +2 more
exaly  

Paired Comparison of Vascular Wall Reactions to Palmaz Stents, Strecker Tantalum Stents, and Wallstents in Canine Iliac and Femoral Arteries

Circulation, 1996
Klemens H Barth, Renu Virmani, Steven V Lossef   +2 more
exaly  

Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents

Circulation, 2012
Hyeon-Cheol Gwon, Joo-Yong Hahn, Kyung Woo Park   +2 more
exaly  

Comparison of Coronary Artery Stenting Outcomes in the Eras Before and After the Introduction of Drug-Eluting Stents

Circulation, 2008
Edward L Hannan, Michael Rácz, David R Holmes   +2 more
exaly  

Repeat Dilation of Intravascular Stents in Congenital Heart Defects

Circulation, 1995
Frank F InG, Ronald G Grifka, Michael R Nihill   +2 more
exaly  

Pathology of Drug-Eluting Stents in Humans

Journal of the American College of Cardiology, 2006
Aloke V Finn, Andrew Farb, Elena Ladich   +2 more
exaly